Sites
Approved contributions by @candyjkswift to the Viesearch index.
Siltuximab: Anti-Human IL-6 Therapeutic Antibody
Siltuximab is a chimeric monoclonal antibody binding to interleukin-6. It's been investigated for the treatment of metastatic renal cell cancer, prostate cancer, and Castleman's disease.
Muromonab
Muromonab is a purified murine monoclonal antibody directed against the CD3 receptor on human T-cells. It is 93% monomeric immune globulin G type 2a (IgG2a).